CYCLERION THERAPEUTICS, INC. Gain (Loss) on Termination of Lease
CYCLERION THERAPEUTICS, INC. (CYCN) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2023-03-22
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for the quarter ending 2022-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for the quarter ending 2022-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for the quarter ending 2021-09-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for the quarter ending 2021-06-30 was -$881.00K.
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for fiscal 2022 was $0.00.
- CYCLERION THERAPEUTICS, INC. gain (loss) on termination of lease for fiscal 2021 was -$881.00K.
| Period end | Gain (Loss) on Termination of Lease | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 3 month as first filed | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 6 month as first filed | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 9 month as first filed | Gain (Loss) on Termination of Lease 12 month | Gain (Loss) on Termination of Lease 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 | ||||||||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | |||||||
| 2021-12-31 | -$881.00K 10-K · filed 2023-03-22 | $6.30M 10-K · filed 2022-02-24 | |||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | -$881.00K 10-Q · filed 2022-11-03 | $6.30M 10-Q · filed 2021-11-09 | ||||||
| 2021-06-30 | -$881.00K 10-Q · filed 2022-08-09 | $6.30M 10-Q · filed 2021-07-29 | -$881.00K 10-Q · filed 2022-08-09 | $6.30M 10-Q · filed 2021-07-29 | |||||
| 2021-04-30 | $900.00K 10-Q · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |